Top Tweets for #SEROCOV

almost 5 years ago

A new preprint from our #SEROCOV cohort @hospitalclinic is out: "Determinants of early antibody responses to COVID-19 mRNA vaccines in exposed and naive healthcare workers" https://t.co/iVJUZsrNOW @ISGLOBALorg @gmoncu @martaribesa @MalariaImmuno @ToniTrilla

0

8

2

0

almost 5 years ago

🔬 #ISGlobal and @hospitalclinic researchers unravel the immunity to #SARS_CoV_2 up to 7 months in healthcare workers. Learn more on the #SEROCOV project on the @NatureMicrobiol blog! #COVID19 cc @MalariaImmuno @NaturePortfolio @martaribesa @NataliaOrHe https://t.co/wD1E1QWFeD

0

9

3

0

almost 5 years ago

Great summary of the #SEROCOV project on #SARSCoV2 antibody seroprevalence and characterization of humoral response among #HCW at @hospitalclinic and @ISGLOBALorg @NatureMicrobiol @NataliaOrHe @martaribesa @gmoncu @MalariaImmuno

0

10

3

0

about 5 years ago

🤧The results of the #SEROCOV study suggest that the antibodies against human cold coronaviruses (HCoV) could confer cross-protection against #COVID19 infection or disease. 🦠People who were infected by #SARS_CoV_2 had lower levels of HCoV antibodies. 🔗 https://t.co/HynWawnhKa

ISGLOBALorg's tweet photo. 🤧The results of the #SEROCOV study suggest that the antibodies against human cold coronaviruses (HCoV) could confer cross-protection against #COVID19 infection or disease.

🦠People who were infected by #SARS_CoV_2 had lower levels of HCoV antibodies.

🔗 https://t.co/HynWawnhKa https://t.co/OjgfWuHSrG

0

6

4

0

Kiran Mazumdar-Shaw

@kiranshaw

about 5 years ago

Results from #SEROCOV study @ISGLOBALorg shows that antibodies to #SARS_CoV_2 remain stable, or even increase, 7 months after infection. Also suggests that pre-existing antibodies against common cold coronaviruses could protect against #COVID19 https://t.co/M85fOk6h1U

0

31

3

1

0

about 5 years ago

Per primer cop s'ha avaluat la resposta d'anticossos enfront d'un ampli panell d'antígens del #SARS_CoV_2 durant 7 mesos i, segons l'estudi #SEROCOV d'#ISGlobal i @hospitalclinic, es mantenen estables, o fins i tot augmenten. cc @EITHealth @UniBarcelona https://t.co/M7IWYAod7S

0

5

1

0

about 5 years ago

💬 "We even saw an increase of IgG anti-Spike antibodies in 75% of the participants from month 5 onwards, without any evidence of re-exposure to the #coronavirus,” says @gmoncu, senior co-author of the #SEROCOV study. ➡️ https://t.co/x2IJHof7M0

ISGLOBALorg's tweet photo. 💬 "We even saw an increase of IgG anti-Spike antibodies in 75% of the participants from month 5 onwards, without any evidence of re-exposure to the #coronavirus,” says @gmoncu, senior co-author of the #SEROCOV study.

➡️ https://t.co/x2IJHof7M0 https://t.co/fDjZ43Enti

0

5

2

0

about 5 years ago

"This is the first study that evaluates antibodies to such a large panel of #SARS_CoV_2 antibodies over 7 months." 👩🏼‍🔬 #CarlotaDobaño followed a cohort of healthcare workers at the @hospitalclinic (#SEROCOV study) from the beginning of the #COVID19 pandemic.

ISGLOBALorg's tweet photo. "This is the first study that evaluates antibodies to such a large panel of #SARS_CoV_2 antibodies over 7 months."

👩🏼‍🔬 #CarlotaDobaño followed a cohort of healthcare workers at the @hospitalclinic (#SEROCOV study) from the beginning of the #COVID19 pandemic. https://t.co/uFa8whiyRu

1

4

0

Urgències Mèdiques @urgemcat

about 5 years ago

New results from the #SEROCOV study are published in @NatureComms:👇🏼 🛡 Antibodies to #SARS_CoV_2 remain stable, or even increase, 7 months after infection 🦠 Pre-existing antibodies against common cold coronaviruses could protect against #COVID19 https://t.co/4KleFevXkK

1

8

7

0

over 6 years ago

Estudi #SEROCOV-1 Només l’11% del personal sanitari de @hospitalclinic de #BCN amb infecció activa o passada per #coronavirus. El virus encara té molt de terreny disponible per sembrar. Protegir-nos !!! https://t.co/vYzS3FjXxB

0

5

3

0

Montse Lamoglia @montse_lamoglia

over 6 years ago

Reunión de equipo #SEROCOV liderada por @agbasteiro @hospitalclinic @ISGLOBALorg

over 6 years ago

#SEROCOV clinical team keeping up the smiles and training on the #cough etiquette in the time of #COVID19 💪💪💪💪 @ISGLOBALorg @hospitalclinic @MalariaImmuno

agbasteiro's tweet photo. #SEROCOV clinical team keeping up the smiles and training on the #cough etiquette in the time of #COVID19

💪💪💪💪

@ISGLOBALorg @hospitalclinic @MalariaImmuno https://t.co/hpfKWNM2dA

0

17

2

0

3

1

0

over 6 years ago

#SEROCOV clinical team keeping up the smiles and training on the #cough etiquette in the time of #COVID19 💪💪💪💪 @ISGLOBALorg @hospitalclinic @MalariaImmuno

0

17

2

0